Ubiquitin-Dependent Proteolysis: Specificity & Mechanism

泛素依赖性蛋白水解:特异性

基本信息

  • 批准号:
    7911607
  • 负责人:
  • 金额:
    $ 34.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1982
  • 资助国家:
    美国
  • 起止时间:
    1982-02-01 至 2012-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: The long-term goal of this research is to understand how the ubiquitin domain is recognized as a targeting signal. The ubiquitin domain is a diverse and widely used targeting signal that is post- translationally attached to a variety of cellular proteins. The ubiquitin pathway is implicated in growth control (cancer and apoptosis), signal transduction (inflammation and transcriptional control), and the stress response (protein quality control, neurodegeneration, and genome integrity). Conjugation of the domain serves to modify the localization or activities of the target protein. Conjugation of a single ubiquitin to histones is involved in chromatin and DMA transactions and as a sorting signal in endosomal sorting pathways. NEDD8 conjugation regulated ubiquitin E3 liganses while SUMO-1 (small ubiquitin-like modifier) conjugation is widely involved in nuclear protein metaboslism. Poly ubiquitination (or SUMOylation) of target proteins is achieved by attachment of one ubiquitin to another through lysine residues. K48-Iinked polyubiquitin is a signal for delivery of the target protein to the proteasome for proteolysis while K63-linked chains are involved in assembling signaling complexes in the NFkB pathway and play some undetermined role in DNA repair. Linkages through lysines 6,11, 29, and 33 are also observed, although the function of these chains, as well as that of polySUMO-2/3 chains is completely unknown. The unifying hypothesis is that there are specific receptors or adapters that specifically recognize the different ubiquitin domains and contexts and that subsequently direct the conjugated protein to the appropriate cellular fate. This study proposes to define some of the potential roles of the different chain linkages by studying polyubiquitin recognition and defining the receptors and binding proteins that distinguish among different version of the ubiquitin domain. Two approaches are used here. First, a directed approach uses deubiquitinating enzymes as a model for specific recognition of polyubiquitin, either by direct recognition (USP5/isopeptidase T, Aim 1) or by adapter-assisted recognition of specific substrates (BAP1, Aim 2). Second, a modern systems biology approach takes advantage of our synthesis of polyubiquitin chain analogs to identify ubiquitin-binding proteins with specificity for different ubiquitin domains and different architectures (Aim 3).
本研究的长期目标是了解泛素结构域如何被识别为靶向信号。泛素结构域是一种多样且广泛使用的靶向信号,其在免疫后连接到多种细胞蛋白。泛素途径与生长控制(癌症和凋亡)、信号转导(炎症和转录控制)和应激反应(蛋白质质量控制、神经变性和基因组完整性)有关。结构域的缀合用于修饰靶蛋白的定位或活性。单个泛素与组蛋白的缀合涉及染色质和DMA交易,并且作为内体分选途径中的分选信号。NEDD 8缀合调节泛素E3配体,而SUMO-1(小泛素样修饰物)缀合广泛参与核蛋白代谢。靶蛋白的多聚泛素化(或SUMO化)是通过赖氨酸残基将一个泛素连接到另一个泛素上来实现的。K48-连接的多聚泛素是将靶蛋白递送至蛋白酶体以进行蛋白水解的信号,而K63-连接的链参与NF κ B途径中的信号复合物的组装,并且在DNA修复中发挥一些未确定的作用。还观察到通过赖氨酸6、11、29和33的连接,尽管这些链以及polySUMO-2/3链的功能完全未知。统一的假设是,存在特异性受体或衔接子,其特异性识别不同的泛素结构域和背景,并随后将缀合的蛋白质引导至适当的细胞命运。本研究提出通过研究多聚泛素识别和定义区分不同版本的泛素结构域的受体和结合蛋白来定义不同链连接的一些潜在作用。这里使用了两种方法。首先,定向方法使用去泛素化酶作为多聚泛素特异性识别的模型,通过直接识别(USP 5/异肽酶T,Aim 1)或通过特定底物的衔接子辅助识别(BAP 1,Aim 2)。第二,现代系统生物学方法利用我们的多聚泛素链类似物的合成来鉴定对不同泛素结构域和不同结构具有特异性的泛素结合蛋白(目的3)。

项目成果

期刊论文数量(26)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
125I-ubiquitin is kinetically invalid as a tracer radiolabel for studies of ATP-dependent proteolysis.
125I-泛素作为 ATP 依赖性蛋白水解研究的示踪放射性标记在动力学上无效。
An emerging model for BAP1's role in regulating cell cycle progression.
BAP1在调节细胞周期进程中的作用的新兴模型。
  • DOI:
    10.1007/s12013-011-9184-6
  • 发表时间:
    2011-06
  • 期刊:
  • 影响因子:
    2.6
  • 作者:
    Eletr, Ziad M.;Wilkinson, Keith D.
  • 通讯作者:
    Wilkinson, Keith D.
Alcohol-induced conformational changes of ubiquitin.
酒精诱导的泛素构象变化。
The large scale purification of ubiquitin from human erythrocytes.
  • DOI:
    10.1080/00327488508062433
  • 发表时间:
    1985
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A. Haas;K. Wilkinson
  • 通讯作者:
    A. Haas;K. Wilkinson
Protein ubiquitination: a regulatory post-translational modification.
  • DOI:
  • 发表时间:
    1987-10
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Wilkinson Kd
  • 通讯作者:
    Wilkinson Kd
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KEITH D WILKINSON其他文献

KEITH D WILKINSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KEITH D WILKINSON', 18)}}的其他基金

Ubiquitin and regulation of prion induction by a short-lived protein
泛素和短寿命蛋白对朊病毒诱导的调节
  • 批准号:
    8536841
  • 财政年份:
    2011
  • 资助金额:
    $ 34.08万
  • 项目类别:
Ubiquitin and regulation of prion induction by a short-lived protein
泛素和短寿命蛋白对朊病毒诱导的调节
  • 批准号:
    8042325
  • 财政年份:
    2011
  • 资助金额:
    $ 34.08万
  • 项目类别:
Ubiquitin and regulation of prion induction by a short-lived protein
泛素和短寿命蛋白对朊病毒诱导的调节
  • 批准号:
    8725684
  • 财政年份:
    2011
  • 资助金额:
    $ 34.08万
  • 项目类别:
Ubiquitin and regulation of prion induction by a short-lived protein
泛素和短寿命蛋白对朊病毒诱导的调节
  • 批准号:
    8325025
  • 财政年份:
    2011
  • 资助金额:
    $ 34.08万
  • 项目类别:
Ubiquitin-Dependent Proteolysis: Specificity & Mechanism
泛素依赖性蛋白水解:特异性
  • 批准号:
    7933334
  • 财政年份:
    2009
  • 资助金额:
    $ 34.08万
  • 项目类别:
Ubiquitin and Cellular Regulation
泛素和细胞调节
  • 批准号:
    7644015
  • 财政年份:
    2006
  • 资助金额:
    $ 34.08万
  • 项目类别:
Ubiquitin and Cellular Regulation
泛素和细胞调节
  • 批准号:
    7253933
  • 财政年份:
    2006
  • 资助金额:
    $ 34.08万
  • 项目类别:
HTS for Inhibitors of BAP1,BRCA:Deubiquinating(RMI)
BAP1、BRCA 抑制剂的 HTS:去泛素化 (RMI)
  • 批准号:
    7058567
  • 财政年份:
    2005
  • 资助金额:
    $ 34.08万
  • 项目类别:
Functions of Ub-like Proteins & Processing Proteases
Ub 样蛋白的功能
  • 批准号:
    6521874
  • 财政年份:
    2002
  • 资助金额:
    $ 34.08万
  • 项目类别:
Functions of Ub-like Proteins & Processing Proteases
Ub 样蛋白的功能
  • 批准号:
    6785957
  • 财政年份:
    2002
  • 资助金额:
    $ 34.08万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 34.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 34.08万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 34.08万
  • 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 34.08万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 34.08万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 34.08万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 34.08万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 34.08万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 34.08万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 34.08万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了